We also achieved significant protective neuropathological and neurobehavioral effects by intraperitoneal injection of CPAG‐1, a gain‐of‐function ligand of PGRMC2, in our murine model of ischemic stroke. This evidence concerns the gene PGRMC2 and ischemic stroke.